Department of Orthopaedic Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea; Department of Orthopaedic Surgery, Eulji University Hospital, Daejeon, Republic of Korea.
Department of Orthopaedic Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
J Shoulder Elbow Surg. 2021 Sep;30(9):2127-2133. doi: 10.1016/j.jse.2020.12.013. Epub 2021 Jan 30.
The study aimed (1) to determine patient acceptable symptomatic state (PASS) values for the pain visual analog scale (PVAS), range-of-motion (ROM) scale difference, Mayo Elbow Performance Score (MEPS), and Self-evaluation Elbow (SEE) following osteocapsular arthroplasty for primary elbow osteoarthritis and (2) to determine factors for achieving the PASS.
The study analyzed retrospectively collected osteocapsular arthroplasty registry data from January 2010 to April 2019. Fifty patients were evaluated, and anchor questions for deriving PASS values were administered at a 1-year follow-up. PASS values for the PVAS score, ROM difference, MEPS, and SEE score were derived using a sensitivity- and specificity-based approach. Univariate and multivariate logistic regression analyses were performed to determine factors for achieving the PASS. A subgroup comparison analysis based on age was also conducted.
The PASS value was 1.0 for the PVAS score, 15° for ROM difference, 75 for the MEPS, and 60 for the SEE score. Older age (≥65 years) showed significantly lower odds ratios for achieving the PASS for the PVAS score (0.888; 95% confidence interval, 0.804-0.981; P = .032) and ROM (0.861; 95% confidence interval, 0.760-0.976; P = .020).
Reliable PASS values were derived for the PVAS score, ROM difference, MEPS, and SEE score after osteocapsular arthroplasty. The PASS values defined in this study can be implemented as clinically relevant targets in patients undergoing osteocapsular arthroplasty. An analysis of factors that affect clinical symptom improvement showed that older age (≥65 years) was significantly correlated with lower PASS values for the PVAS score and ROM.
本研究旨在:(1) 确定原发性肘关节炎患者行囊状骨切除术(osteoacapular arthroplasty)后,疼痛视觉模拟评分(PVAS)、关节活动度(ROM)差值、 Mayo 肘部功能评分(MEPS)和自我评估肘部(SEE)的可接受症状状态(PASS)值;(2) 确定达到 PASS 的影响因素。
本研究回顾性分析了 2010 年 1 月至 2019 年 4 月期间的囊状骨切除术登记数据。对 50 名患者进行评估,并在 1 年随访时进行了确定 PASS 值的锚定问题。采用基于灵敏度和特异性的方法得出 PVAS 评分、ROM 差值、MEPS 和 SEE 评分的 PASS 值。采用单变量和多变量逻辑回归分析确定达到 PASS 的影响因素。还根据年龄进行了亚组比较分析。
PVAS 评分、ROM 差值、MEPS 和 SEE 评分的 PASS 值分别为 1.0、15°、75 和 60。年龄≥65 岁患者达到 PVAS 评分(比值比,0.888;95%置信区间,0.804-0.981;P =.032)和 ROM(0.861;95%置信区间,0.760-0.976;P =.020)PASS 的比值明显较低。
囊状骨切除术治疗后,可靠的 PASS 值可用于 PVAS 评分、ROM 差值、MEPS 和 SEE 评分。本研究中定义的 PASS 值可作为囊状骨切除术患者的临床相关目标。对影响临床症状改善的因素分析表明,年龄≥65 岁与 PVAS 评分和 ROM 的 PASS 值较低显著相关。